Phase Holographic Imaging, PHI, recently created a US-based alliance for advancing cell-based biomanufacturing with Wake Forest Institute for Regenerative Medicine, BioSpherix, QIAGEN and global analytics company SAS. At their new offices at the Regenerative Medicine Hub in North Carolina, PHI will develop its non-invasive technology for cell quality control for use in this emerging field of modern medicine. Kersti Alm, Chief Scientific Officer at PHI, visited BioStock’s studio to talk about the alliance and PHI’s pivotal role in the collaboration.
Watch the interview with Phase Holographic Imaging’s CSO Kersti Alm, below.The content of BioStock’s news and analyses is independent but the work of BioStock is to a certain degree financed by life science companies. The above article concerns a company from which BioStock has received financing.